For so Livy (after he had described Cato Major in these words, In illo viro tantum robur corporis et animi fuit, ut quocunque loco natus
esset, fortunam sibi facturus videretur) falleth upon that, that he had versatile ingenium.
We are very pleased that New South Wales has upgraded to our latest AABR product, reflecting Australia's commitment to base their newborn hearing screening program exclusively on Natus
Ken Traverso, Natus
Vice President of Sales and Marketing noted, "With both a direct and dealer sales organization, we wanted to partner with a company that could service our diversity.
acquired all outstanding shares of Alpine Biomed capital stock for $43.
Jim Hawkins, President and Chief Executive Officer of Natus
commented, "For many years, the vast majority of infants born in California have had their hearing screened with our proprietary ALGO hearing screening devices and disposable supplies.
acquired Hawaii Medical for a cash price of $2.
acquired all outstanding shares of NeuroCom capital stock for $18 million, exclusive of direct costs of the acquisition.
As discussed in its May 1, 2008 first quarter 2008 financial results conference call, Natus
will update in the near future its 2008 financial guidance in light of the completion of the Sonamed acquisition.
has agreed to acquire all outstanding shares of SonaMed capital stock in a cash transaction.
In December 2006, Natus
announced that it had received premarket approval ("PMA") from the FDA to market the Cool-Cap, a Class III medical device.
On November 29, 2007, Natus
completed its acquisition of Excel-Tech Ltd.
AND LECTEC SIGN INVESTMENT AND DEVELOPMENT PACTS